![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 940-948, March 2003
Division of Molecular Pharmacology and Neuroscience, Nagasaki
University Graduate School of Biomedical Sciences, Nagasaki, Japan
(M.H.R., M.I., S.K., T.K., H.U.); and Central Research Laboratories,
Maruishi Pharmaceutical Co. Ltd., Osaka, Japan (S.B.)
Here, we investigated the mechanism of the antihyperalgesic effect of
capsaicin cream in the nerve injury-induced neuropathic pain model in
mice. In naive mice, application of capsaicin cream onto footpad caused
no significant changes in the thermal latency in contrast to the severe
thermal hyperalgesia induced by a capsaicin ointment. On the other
hand, application of the cream 3 h before test concentration
dependently reversed both thermal and mechanical hyperalgesia observed
after partial sciatic nerve injury in mice. In algogenic-induced
nociceptive flexion (ANF) test, application of 0.1% capsaicin cream in
naive mice blocked intraplantar (i.pl.) nociceptin- and ATP-induced
flexion responses, whereas prostaglandin I2
(PGI2) agonist-induced responses were unaffected. After
nerve injury PGI2 agonist-induced flexion responses were
hypersensitized, and capsaicin cream concentration dependently blocked
these hyperalgesic responses. Intraplantar injection of capsaicin
solution in ANF test also produced potent flexion responses in naive
mice that were lost after neonatal capsaicin-treatment. Partial sciatic nerve injury in neonatal capsaicin-treated mice caused reappearance of
i.pl. capsaicin-induced flexion responses, suggesting novel expression
of capsaicin receptors due to injury. The PGI2
agonist-induced responses were also hypersensitized in such injured
mice. Capsaicin cream completely reversed both i.pl. capsaicin- or
i.pl. PGI2 agonist-induced hyperalgesia in neonatal
capsaicin-treated injured mice. Finally, novel expression of VR1
receptors on neonatal capsaicin-insensitive neurons after nerve injury
was confirmed by immunohistochemistry. The newly expressed VR1
receptors after nerve injury were mainly confined to A-fibers.
Together, our results suggest that novel expression of capsaicin
receptors in neuropathic condition contributes to the analgesic effects
of the capsaicin cream.
This article has been cited by other articles:
![]() |
I. Kissin, C. F. Freitas, and E. L. Bradley Jr Perineural Resiniferatoxin Prevents the Development of Hyperalgesia Produced by Loose Ligation of the Sciatic Nerve in Rats Anesth. Analg., May 1, 2007; 104(5): 1210 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Jhaveri, D. Richardson, D. A. Kendall, D. A. Barrett, and V. Chapman Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain J. Neurosci., December 20, 2006; 26(51): 13318 - 13327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsumoto, M. Inoue, A. Hald, W. Xie, and H. Ueda Inhibition of Paclitaxel-Induced A-Fiber Hypersensitization by Gabapentin J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 735 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Honore, C. T. Wismer, J. Mikusa, C. Z. Zhu, C. Zhong, D. M. Gauvin, A. Gomtsyan, R. El Kouhen, C.-H. Lee, K. Marsh, et al. A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 410 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-R. Ji and G. Strichartz Cell Signaling and the Genesis of Neuropathic Pain Sci. Signal., September 28, 2004; 2004(252): re14 - re14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rashid, M. Inoue, K. Toda, and H. Ueda Loss of Peripheral Morphine Analgesia Contributes to the Reduced Effectiveness of Systemic Morphine in Neuropathic Pain J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 380 - 387. [Abstract] [Full Text] |
||||
![]() |
M. H. Rashid, M. Inoue, M. Matsumoto, and H. Ueda Switching of Bradykinin-Mediated Nociception Following Partial Sciatic Nerve Injury in Mice J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1158 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rashid, M. Inoue, S. Bakoshi, and H. Ueda Increased Expression of Vanilloid Receptor 1 on Myelinated Primary Afferent Neurons Contributes to the Antihyperalgesic Effect of Capsaicin Cream in Diabetic Neuropathic Pain in Mice J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 709 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, T. Kawashima, R. G. Allen, and H. Ueda Nocistatin and Prepro-Nociceptin/Orphanin FQ 160-187 Cause Nociception through Activation of Gi/o in Capsaicin-Sensitive and of Gs in Capsaicin-Insensitive Nociceptors, Respectively J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, T. Kawashima, H. Takeshima, G. Calo, A. Inoue, Y. Nakata, and H. Ueda In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 495 - 501. [Abstract] [Full Text] [PDF] |
||||